Literature DB >> 19850457

Glucose metabolism and programmed cell death: an evolutionary and mechanistic perspective.

Ayala King1, Eyal Gottlieb.   

Abstract

Over the last decade, cellular glucose metabolism has emerged as a central player in the mechanisms of programmed cell death (PCD). We examined the metabolic foundations of apoptosis from a Darwinian context and suggest that PCD has evolved from the cellular response to metabolic stress, most notably in relation to glucose metabolism. Whilst apoptosis and other forms of PCD are essential to the development, maintenance and survival of multicellular organisms, it is now evident that controlled and selective cell death confers fitness advantages in unicellular organisms. All species may thus harbour a fundamental relationship between the availability of basic nutrients and life/death decisions. This evolutionary perspective may inform our understanding of PCD in its many guises.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850457     DOI: 10.1016/j.ceb.2009.09.009

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  17 in total

1.  Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

Authors:  Isabel Garcia-Cao; Min Sup Song; Robin M Hobbs; Gaelle Laurent; Carlotta Giorgi; Vincent C J de Boer; Dimitrios Anastasiou; Keisuke Ito; Atsuo T Sasaki; Lucia Rameh; Arkaitz Carracedo; Matthew G Vander Heiden; Lewis C Cantley; Paolo Pinton; Marcia C Haigis; Pier Paolo Pandolfi
Journal:  Cell       Date:  2012-03-06       Impact factor: 41.582

2.  Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors.

Authors:  Samuel K Houston; Yolanda Pina; Jennifer Clarke; Tulay Koru-Sengul; William K Scott; Lubov Nathanson; Amy C Schefler; Timothy G Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-23       Impact factor: 4.799

3.  Function of hTim8a in complex IV assembly in neuronal cells provides insight into pathomechanism underlying Mohr-Tranebjærg syndrome.

Authors:  Yilin Kang; Alexander J Anderson; Thomas Daniel Jackson; Catherine S Palmer; David P De Souza; Kenji M Fujihara; Tegan Stait; Ann E Frazier; Nicholas J Clemons; Deidreia Tull; David R Thorburn; Malcolm J McConville; Michael T Ryan; David A Stroud; Diana Stojanovski
Journal:  Elife       Date:  2019-11-04       Impact factor: 8.140

Review 4.  Targeting metabolic transformation for cancer therapy.

Authors:  Daniel A Tennant; Raúl V Durán; Eyal Gottlieb
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

5.  Role of hexokinase-1 in the survival of HIV-1-infected macrophages.

Authors:  Satarupa Sen; Rafal Kaminiski; Satish Deshmane; Dianne Langford; Kamel Khalili; Shohreh Amini; Prasun K Datta
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 6.  Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies.

Authors:  John Joson Ng; S Tiong Ong
Journal:  Curr Hematol Malig Rep       Date:  2022-10-19       Impact factor: 4.213

Review 7.  Sugar for the brain: the role of glucose in physiological and pathological brain function.

Authors:  Philipp Mergenthaler; Ute Lindauer; Gerald A Dienel; Andreas Meisel
Journal:  Trends Neurosci       Date:  2013-08-20       Impact factor: 13.837

8.  Recent advancements in toxin and antitoxin systems involved in bacterial programmed cell death.

Authors:  Ming-Xi Hu; Xiao Zhang; Er-Li Li; Yong-Jun Feng
Journal:  Int J Microbiol       Date:  2010-12-27

9.  A novel pyruvate kinase M2 activator compound that suppresses lung cancer cell viability under hypoxia.

Authors:  Dong Joon Kim; Young Soo Park; Nam Doo Kim; Sang Hyun Min; Yeon-Mi You; Yuri Jung; Han Koo; Hanmi Noh; Jung-Ae Kim; Kyung Chan Park; Young Il Yeom
Journal:  Mol Cells       Date:  2015-03-26       Impact factor: 5.034

10.  Neuronal Culture Microenvironments Determine Preferences in Bioenergetic Pathway Use.

Authors:  Juliane Sünwoldt; Bert Bosche; Andreas Meisel; Philipp Mergenthaler
Journal:  Front Mol Neurosci       Date:  2017-09-29       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.